Business Details
15 Years
experience
Your Trusted Partner for Global Pharmaceutical Therapies
Founded in 2011, AMAG Pharmaceuticals is a private equity-backed global specialty pharmaceutical company dedicated to delivering therapeutic solutions for patients with life-threatening conditions and chronic illnesses. Our mission focuses on transforming untapped potential into global medical therapies that improve patient outcomes. With operations in over 50 countries, we maintain long-term supply agreements with 10+ manufacturers to ensure supply chain security. Our values emphasize collaborative teamwork, relentless pursuit of patient-centric goals, agility in adapting to industry changes, and transparency in all our actions. We prioritize patient safety and ethical accountability, maintaining compliance with global regulatory standards.Our executive leadership team brings decades of combined experience in pharmaceutical innovation, supply chain management, and clinical development. Through strategic partnerships with world-class pharmaceutical companies and contract manufacturing organizations, we ensure uninterrupted access to high-quality medications. Our portfolio includes 12+ brands, with products like Alvesco, Duaklir, Feraheme, and Tudorza, offering affordable and therapeutically equivalent alternatives. We invest in product development, including line extensions and novel late-stage clinical programs, to address unmet medical needs. Our operational excellence and commitment to innovation position us as a trusted partner in the global healthcare ecosystem.
Services
Respiratory Medications
Hematology Therapies
Cardiovascular Treatments
Gastroenterology Solutions
Allergy Medications
Authorized Generics
Clinical Development
Supply Chain Management
Patient Assistance Programs
Pharmaceutical Partnerships
Details
- Year established: 2011
Highlights and features
- We offer 12+ therapeutic brands distributed in 50+ countries.
- Our team includes executives with 20+ years of pharmaceutical industry experience.
- We maintain long-term supply agreements with 10+ manufacturers for reliability.
- Our portfolio includes FDA-approved authorized generics and novel clinical programs.
- We prioritize patient-centric values with a focus on ethical accountability.
Services
Respiratory Medications
AMAG Pharmaceuticals develops respiratory medications like Alvesco and Duaklir for managing asthma and chronic obstructive pulmonary disease. These therapies provide patients with long-acting control and improved quality of life. Our products combine advanced formulation technology with rigorous safety standards for effective symptom management.
Hematology Therapies
Our hematology portfolio includes Feraheme for treating iron deficiency anemia in adult patients with chronic kidney disease. These therapies address critical gaps in blood disorder management through targeted delivery mechanisms and clinical efficacy. We focus on expanding access to specialized treatments for underserved patient populations.
Cardiovascular Treatments
Covis offers cardiovascular medications like Sular for hypertension management, ensuring patients receive reliable, cost-effective solutions. Our formulations prioritize consistent dosing and bioavailability to optimize heart health outcomes. We collaborate with healthcare providers to enhance therapeutic adherence and patient education.
Gastroenterology Solutions
Our gastroenterology products, including Prilosec for acid reflux, provide evidence-based treatments for digestive disorders. These medications are developed with patient comfort and long-term safety in mind. We emphasize clinical research to validate efficacy across diverse patient demographics.
Patient Assistance Programs
Covis operates patient assistance programs to help individuals access prescribed therapies through financial aid and insurance navigation. These initiatives reduce barriers to treatment for underserved communities. Our dedicated support team ensures timely enrollment and personalized guidance for eligible patients.
People
Michael Porter
Chief Executive Officer
Michael Porter has over 20 years of private equity and pharmaceutical industry experience. He led Covis' acquisition of Global rights for Alvesco and Omnaris, and oversaw its sale to Apollo in 2020. He holds an MBA from Columbia University and speaks six languages.
Raghav Chari
Chief Innovation Officer
Raghav Chari brings 25 years of biopharmaceutical expertise, including leadership roles at Promius Pharma and Dr. Reddy's Laboratories. He founded startups leveraging AI for drug discovery and holds a PhD in Physics from Princeton University.
Fabio Fazio
EVP, Global Head of Quality
Fabio Fazio ensures compliance with global manufacturing standards, drawing on prior roles at Biogen Idec and GlaxoSmithKline. He holds a PhD in Chemistry from the University of Wuppertal and oversees regulatory inspections and quality systems.
Christine Poulin
President, North America
Christine Poulin has 25+ years of pharmaceutical leadership experience, including roles at Teva and Pfizer. She holds an MBA from Wharton and specializes in market access strategies and product launches in North America.
Nick Kelly
Senior Vice President, Supply Chain
Nick Kelly has 20+ years of supply chain leadership in pharma, including roles at Cardinal Health and Johnson & Johnson. He holds a BSc in Business Information Technology and specializes in end-to-end logistics optimization.
Questions
What therapeutic areas does Covis Pharma specialize in?
Covis focuses on respiratory, hematology, cardiovascular, gastroenterology, and allergy treatments.
Are Covis products available globally?
Yes, our therapies are marketed in 50+ countries through strategic distribution partnerships.
How can patients access Covis medications?
Patients can obtain prescriptions through healthcare providers or contact our assistance programs for support.
Does Covis offer generic alternatives?
Yes, we provide authorized generics like Alvesco and Duaklir through partnerships.
How does Covis ensure product quality?
We maintain strict compliance with global regulatory standards and partner with certified manufacturers.
